News Conference News TCT 2016 COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events Michael O'Riordan November 01, 2016
Presentation TCT 2016 How to Manage BRS Thrombosis (With Case Examples) Presenter: Ashok Seth, Pieter C. Smits, Anuruck Jeamanukoolkit November 01, 2016
Presentation TCT 2016 Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience Presenter: Stephen G. Ellis, Patrick W. Serruys, Serban Puricel November 01, 2016
Presentation TCT 2016 TCT 313: Incidence and Predictors of Very Late Major Adverse Cardiac Events After Metallic Stents: A Patient-Level Pooled Analysis from Seventeen Randomized Trials Presenter: Serban Puricel, Clemens von Birgelen November 01, 2016
Presentation TCT 2016 TCT 312: Increased Cardiac Death and Stent Thrombosis in Chronic Obstructive Pulmonary Disease Patients Undergoing Percutaneous Coronary Intervention. An Analysis of the BASKET-PROVE I and II trials. Presenter: Serban Puricel, Clemens von Birgelen November 01, 2016
Presentation TCT 2016 TCT 401: Bioresorbable Scaffolds And Thrombosis: Insights From The GHOST-EU (Gauging coronary Healing with Bioresorbable Scaffolding Platforms in Europe) Registry Presenter: Serban Puricel, Clemens von Birgelen November 01, 2016
Presentation TCT 2016 TCT 402: Relationship Between Bioresorbable Scaffold Sizing and Scaffold Thrombosis: A Pooled Analysis of ABSORB Trials Presenter: Serban Puricel, Clemens von Birgelen November 01, 2016
News Industry News TCT 2016 Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures November 01, 2016
News Industry News Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque November 01, 2016
News Conference News TCT 2016 New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts Yael L. Maxwell October 31, 2016
News Industry News TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies October 31, 2016
News Industry News First-In-Human Of New Polymer-Free Stent Demonstrates Favorable Angiographic And Imaging-Based Outcomes At Nine-Months October 31, 2016
News Industry News Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease October 31, 2016
News Conference News TCT 2016 EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease Michael O'Riordan October 31, 2016
News Conference News TCT 2016 Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI Yael L. Maxwell October 31, 2016
Presentation TCT 2016 Case Presentation: Evaluation and Management of Recurrent DES Restenosis Presenter: Fernando Alfonso, Stephan Windecker, Adnan K. Chhatriwalla October 30, 2016
Presentation TCT 2016 Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis? Presenter: Fernando Alfonso, Stephan Windecker, Ron Waksman October 30, 2016
Presentation TCT 2016 Prognosis and Treatment Options for DES Restenosis and Re-restenosis Presenter: Fernando Alfonso, Stephan Windecker October 30, 2016
News Conference News TCT 2016 BIONICS: Ridaforolimus-Eluting Stent Noninferior to Zotarolimus Stent at 1 Year TCT Daily Staff October 30, 2016
Presentation TCT 2016 Case Presentation: A Surprise in the Evaluation and Management of Stent Thrombosis Presenter: Fernando Alfonso, Stephan Windecker, Ehrin J. Armstrong October 30, 2016